Healio

Study: Long-acting PrEP could reduce HIV incidence, AIDS deaths in sub-Saharan Africa

Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...
eLife

HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir

In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...
New Atlas

Key HIV weakness could pave way for a cure

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...
European Medical Journal

ART Scale-Up Reduces Orphanhood in HIV-Affected Children

Expansion of antiretroviral therapy in Uganda sharply reduced orphanhood incidence, especially among adolescents, but ...
AOL

Campaigners call for introduction of 'game-changing' HIV drug

Campaigners in Northern Ireland have called for the introduction of a 'game-changing' drug that will prevent HIV. On Friday it was announced cabotegravir (CAB-LA) injections will be introduced in ...
BMJ Global Health

Decomposing gender gaps in HIV service outcomes

This study uses Population-based HIV Impact Assessments survey data to examine factors associated with gender disparities in ...
Healthline

HIV: As Scientists Inch Closer to a Vaccine, Cuts to Funding Could Stall Progress

Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...